Cargando…
Aberrant Notch signaling in gliomas: a potential landscape of actionable converging targets for combination approach in therapies resistance
The current therapeutic protocols and prognosis of gliomas still depend on clinicopathologic and radiographic characteristics. For high-grade gliomas, the standard of care is resection followed by radiotherapy plus temozolomide chemotherapy. However, treatment resistance develops due to different me...
Autores principales: | D’Amico, Maria, De Amicis, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
OAE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9771760/ https://www.ncbi.nlm.nih.gov/pubmed/36627893 http://dx.doi.org/10.20517/cdr.2022.46 |
Ejemplares similares
-
Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance
por: Chimento, Adele, et al.
Publicado: (2022) -
Cdk4 Regulates Glioblastoma Cell Invasion and Stemness and Is Target of a Notch Inhibitor Plus Resveratrol Combined Treatment
por: Giordano, Francesca, et al.
Publicado: (2023) -
Aberrant Signaling Pathways in Glioma
por: Nakada, Mitsutoshi, et al.
Publicado: (2011) -
Aberrant activation of Notch signalling in human breast cancer
por: Stylianou, S, et al.
Publicado: (2006) -
Steroid Receptor Signallings as Targets for Resveratrol Actions in Breast and Prostate Cancer
por: De Amicis, Francesca, et al.
Publicado: (2019)